Aptorum Group Ltd - Class A

Research Aptorum Group Ltd - Class A (APM) on Bullrun: market cap USD 6.30M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAPM
• ExchangeNASDAQ
• CountryUnited Kingdom
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 6.30M
• Financial periodFY2025
• Net income-USD 1.36M

Valuation Snapshot

latest market cap is USD 6.30M.

About Aptorum Group Ltd - Class A

Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types;

Frequently asked questions

What is Aptorum Group Ltd - Class A's market cap?

Aptorum Group Ltd - Class A's market capitalization is USD 6.30M.

What does Aptorum Group Ltd - Class A do?

Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.